Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions
Authors:
Open Access
- 28 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (1) , ofaa604
Abstract
We documented dramatic responses to infliximab in 4 tuberculous meningitis cases with severe paradoxical reactions after effective antibacterial treatment, despite high-dose steroids. In every instance, infliximab was used as a last resort after all other options were exhausted, resulting in delayed initiation that may have adversely affected patient outcomes.Keywords
This publication has 16 references indexed in Scilit:
- A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRISClinical Infectious Diseases, 2015
- Infliximab therapy in two cases of severe neurotuberculosis paradoxical reactionMedical Journal of Australia, 2015
- A Life-Threatening Central Nervous System–Tuberculosis Inflammatory Reaction Nonresponsive to Corticosteroids and Successfully Controlled by Infliximab in a Young Patient With a Variant of Juvenile Idiopathic ArthritisJCR: Journal of Clinical Rheumatology, 2012
- Tuberculous meningitis: a uniform case definition for use in clinical researchThe Lancet Infectious Diseases, 2010
- Tuberculous Meningitis-Related Optic Neuritis: Recovery of Vision With Thalidomide in 4 Consecutive CasesJournal of Child Neurology, 2010
- Adalimumab Treatment of Life‐Threatening TuberculosisClinical Infectious Diseases, 2009
- Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph NodesClinical Infectious Diseases, 2008
- Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated TuberculosisClinical Infectious Diseases, 2005
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Concentrations of Interferon , Tumor Necrosis Factor , and Interleukin-1 in the Cerebrospinal Fluid of Children Treated for Tuberculous MeningitisClinical Infectious Diseases, 1995